A detailed history of Rise Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Rise Advisors, LLC holds 616 shares of AMGN stock, worth $181,104. This represents 0.1% of its overall portfolio holdings.

Number of Shares
616
Previous 627 1.75%
Holding current value
$181,104
Previous $195,000 1.54%
% of portfolio
0.1%
Previous 0.1%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$309.38 - $337.38 $3,403 - $3,711
-11 Reduced 1.75%
616 $198,000
Q2 2024

Jul 09, 2024

BUY
$262.75 - $319.31 $1,051 - $1,277
4 Added 0.64%
627 $195,000
Q1 2024

Apr 09, 2024

BUY
$268.87 - $324.56 $79,585 - $96,069
296 Added 90.52%
623 $177,000
Q4 2023

Jan 10, 2024

BUY
$255.7 - $288.46 $76,710 - $86,538
300 Added 1111.11%
327 $94,000
Q2 2023

Jul 10, 2023

SELL
$214.27 - $253.37 $5,356 - $6,334
-25 Reduced 48.08%
27 $5,000
Q1 2023

Apr 05, 2023

BUY
$225.79 - $275.2 $903 - $1,100
4 Added 8.33%
52 $12,000
Q3 2022

Oct 11, 2022

BUY
$224.46 - $253.15 $224 - $253
1 Added 2.13%
48 $11,000
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $219 - $242
1 Added 2.17%
47 $11,000
Q4 2021

Feb 24, 2022

BUY
$198.88 - $227.6 $9,148 - $10,469
46 New
46 $10.5 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Rise Advisors, LLC Portfolio

Follow Rise Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rise Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rise Advisors, LLC with notifications on news.